Hi All,
just spotted this one, not sure which thread would be most appropriate.
ImmunoGen: Consolidation in the pharmaceutical sector continues! US drugmaker ImmunoGen has agreed to be acquired by research-based pharmaceutical specialist AbbVie for $10.1 billion. AbbVie has thus strengthened its portfolio of cancer treatments, notably by acquiring Elahere, a blockbuster drug approved for ovarian cancer. The transaction is expected to close in mid-2024.
I haven’t had time to look any further however seems relevant to an IMU deal.
Hi All,just spotted this one, not sure which thread would be...
-
- There are more pages in this discussion • 6,660 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605784 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 159880 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |